Given the unprecedented potency of the new AOMs, there is a particular concern about pharmacotherapy-induced weight loss resulting in potentially excessive loss of lean mass, including skeletal muscle, especially in vulnerable patient populations, e.g., those at risk of sarcopenia the progressive loss of muscle mass, muscle quality and strength as a result of the human aging process
Current pricing references cited in this release are listed here: View the current SynergyRx GLP-1 offer (official SynergyRx page)
Avoid driving until you are fully recovered
In animal studies, oral administration of garlic preparations and organosulfur compounds was found to increase the expression and activity of phase II enzymes in a variety of tissues (64-66)
At TrimRx, we believe true, sustainable success comes from a comprehensive, supportive program